Michael Ibara has more than 20 years of experience in clinical research and development. Throughout his career, Ibara has sought to improve healthcare by bringing together healthcare data and digital technologies. His interests include regulatory and policy implications for digital healthcare, exploring the factors needed to allow interoperability of healthcare data for all stakeholders involved, and implications for the use of big data, machine learning and natural language processing to improve our ability to perform regulated clinical research.
Before joining Elligo, Ibara was the head of digital healthcare for the Clinical Data Interchange Standards Consortium (CDISC). There, he led the FDA eSource project and Healthcare Link efforts with registries, clinical trials and mobile health to enable use of real-world data from healthcare for regulated research and decision making. Prior to CDISC, Ibara was head of business development coordination and innovation and also head of pharmacovigilance innovation at Pfizer, where he worked for 15 years in various positions, leading implementations of global systems and large-scale technologies.